Drugs / Levodopa-Carbidopa Intestinal Gel
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00660673 | Nov 2009 → Nov 2021 | Parkinson disease | AbbVie | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levodopa-Carbidopa Intestinal Gel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00660673 ↗ |
| Known as | LCIG | “Levodopa-Carbidopa Intestinal Gel (LCIG)” NCT00660673 ↗ |
| Route | Other | “LCIG for upper-intestinal infusion” NCT00660673 ↗ |